Cantitate/Preț
Produs
Total produse
Vezi coșul
Antiprotozoal Drug Development and Delivery de Alane Beatriz Vermelho

Antiprotozoal Drug Development and Delivery: Topics in Medicinal Chemistry, cartea 39

Editat de Alane Beatriz Vermelho, Claudiu T. Supuran
en Limba Engleză Paperback – 27 iun 2023
This book reviews new promising drug targets for Neglected Tropical Diseases (NTDs), with a special focus on antiprotozoal drugs against trpyanosomatids Trypanosoma cruzi and Leishmania spp. The book offers a comprehensive overview of the most recent studied targets, and it outlines classical and new treatments and delivery strategies. Expert contributors describe new methods of analysis and bio-prospecting for new compounds, and provide a critical perspective of the translational process used in the research and development of new drug candidates.
The book will appeal not only to researchers, students and professionals interested in drug development to protozoan diseases, but also to medicinal chemists in general.

Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 178109 lei  6-8 săpt.
  Springer International Publishing – 27 iun 2023 178109 lei  6-8 săpt.
Hardback (1) 178714 lei  6-8 săpt.
  Springer International Publishing – 26 iun 2022 178714 lei  6-8 săpt.

Din seria Topics in Medicinal Chemistry

Preț: 178109 lei

Preț vechi: 217207 lei
-18% Nou

Puncte Express: 2672
Preț estimativ în valută:
34092€ • 35747$ • 28168£

Carte tipărită la comandă

Livrare economică 30 ianuarie-13 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031068522
ISBN-10: 3031068521
Ilustrații: X, 331 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.48 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Seria Topics in Medicinal Chemistry

Locul publicării:Cham, Switzerland

Cuprins

Classical and Modern Drug Treatments for Leishmaniasis.- Saponins as Potential Antiprotozoa Agents.- Chagas Disease:  Drug Development and Parasite Target.- Targeting carbonic anhydrases from Leishmania spp. and Trypanosoma cruzi as a strategy to obtain new drugs.- New Compounds for the Management of Trypanosoma brucei Infection.- Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs.- Nano and Microstructured Delivery  Systems for Current Antileishmanial Drugs.- Pharmacological Treatment of Malaria.- η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials.- Management of Entamoeba histolytica Infection: Treatment Strategies and Possible New Drug Targets.- Trichomonas vaginalis Pharmacological Treatment.- Beta-Carbonic Anhydrase from  Trichomonas Vaginalis as New  Antiprotozoan Drug Target.- Drugs for the treatment of toxoplasmosis.- Challenges and promises for obtaining new antiprotozoal drugs – what’s going wrong?

Notă biografică

Alane Beatriz Vermelho is Full Professor at the Federal University of Rio de Janeiro (UFRJ), Brazil, where she coordinates the Laboratory of the Biotechnology Network BIONOVAR - Biocatalysis, Bioproducts and Bioenergy Unit. She received her Ph.D. in Microbiology in 1991 from the Institute of Microbiology Paulo de Góes – UFRJ, Brazil, and in 2006 she carried out postdoctoral research at EMBRAPA, a research corporation affiliated with the Brazilian Ministry of Agriculture. She acted as Director of the Microbiology Institute Paulo de Góes of UFRJ and member of the Executive Group of the Industrial Complex of the Life Sciences until 2016. She is currently a member of the Committee for Management and Evaluation of Intellectual Property of UFRJ and GT - Microbiology of the Brazilian Institute of Petroleum, Gas and Biofuels (IBP). She has been actively promoting the academia-industry interaction throughout her career, and is a member of the joint Management Committee UFRJ-Empresas / UFRJ of the technological park.
Claudiu T. Supuran is a Full Professor of Medicinal Chemistry at Dipartimento Neurofarba, Universita` degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche, Florence, Italy. He received his BSc in Chemistry from the Polytechnic University of Bucharest, Romania (1987), and Ph. D. in Chemistry at the same university in 1991. His research interests focus on drug development against Carbonic anhydrases and other enzymes. He has published 1700+ research articles on carbonic anhydrase enzyme research, being one of the most cited medicinal chemists worldwide. His research is also focused on enzyme inhibitors and activators, carbonic anhydrases, heterocyclic chemistry, chemistry of sulfonamides, sulfamates and sulfamides, X-ray crystallography of metallo-enzymes, biologically active organo-element derivatives, quantitative structure-activity relationship (QSAR) studies, metal-based drugs, cyclooxygenases inhibitors, serineproteases, matrix metalloproteinases, bacterial proteases, antivirals, antitumor drugs, ophthalmologic drugs and amino acid derivatives. One sulfonamide carbonic anhydrase inhibitor discovered in his laboratory, SLC-0111, completed Phase I clinical trials as antitumor/antimetastatic agent in 2014 and is presently in Phase Ib/II clinical trials in Canada, being developed for the treatment of advanced, metastatic solid tumors.

Textul de pe ultima copertă

This book reviews new promising drug targets for Neglected Tropical Diseases (NTDs), with a special focus on antiprotozoal drugs against trpyanosomatids Trypanosoma cruzi and Leishmania spp. The book offers a comprehensive overview of the most recent studied targets, and it outlines classical and new treatments and delivery strategies. Expert contributors describe new methods of analysis and bio-prospecting for new compounds, and provide a critical perspective of the translational process used in the research and development of new drug candidates.
The book will appeal not only to researchers, students and professionals interested in drug development to protozoan diseases, but also to medicinal chemists in general.

Caracteristici

Outlines new promising drug targets for Neglected Tropical Diseases Describes new strategies of antiprotozoal drug delivery Supports the UN Sustainable Development Goal on Good Health and Well-being